Charles River Laboratories International Inc (CRL)
195.77
+1.58
(+0.81%)
USD |
NYSE |
Nov 22, 16:00
195.80
+0.03
(+0.02%)
Pre-Market: 20:00
Charles River Laboratories International Total Assets (Quarterly): 8.004B for Sept. 30, 2024
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 8.004B |
| June 30, 2024 | 7.948B |
| March 31, 2024 | 8.153B |
| December 31, 2023 | 8.195B |
| September 30, 2023 | 7.607B |
| June 30, 2023 | 7.772B |
| March 31, 2023 | 7.699B |
| December 31, 2022 | 7.603B |
| September 30, 2022 | 7.383B |
| June 30, 2022 | 7.529B |
| March 31, 2022 | 7.075B |
| December 31, 2021 | 7.024B |
| September 30, 2021 | 7.058B |
| June 30, 2021 | 6.720B |
| March 31, 2021 | 5.809B |
| December 31, 2020 | 5.491B |
| September 30, 2020 | 5.213B |
| June 30, 2020 | 5.241B |
| March 31, 2020 | 5.202B |
| December 31, 2019 | 4.693B |
| September 30, 2019 | 4.583B |
| June 30, 2019 | 4.625B |
| March 31, 2019 | 3.927B |
| December 31, 2018 | 3.856B |
| September 30, 2018 | 3.797B |
| Date | Value |
|---|---|
| June 30, 2018 | 3.866B |
| March 31, 2018 | 3.001B |
| December 31, 2017 | 2.930B |
| September 30, 2017 | 2.866B |
| June 30, 2017 | 2.774B |
| March 31, 2017 | 2.697B |
| December 31, 2016 | 2.712B |
| September 30, 2016 | 2.690B |
| June 30, 2016 | 2.763B |
| March 31, 2016 | 2.104B |
| December 31, 2015 | 2.068B |
| September 30, 2015 | 2.033B |
| June 30, 2015 | 1.886B |
| March 31, 2015 | 1.847B |
| December 31, 2014 | 1.871B |
| September 30, 2014 | 1.842B |
| June 30, 2014 | 1.863B |
| March 31, 2014 | 1.652B |
| December 31, 2013 | 1.633B |
| September 30, 2013 | 1.644B |
| June 30, 2013 | 1.622B |
| March 31, 2013 | 1.604B |
| December 31, 2012 | 1.586B |
| September 30, 2012 | 1.568B |
| June 30, 2012 | 1.546B |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
4.693B
Minimum
Dec 2019
8.195B
Maximum
Dec 2023
6.871B
Average
7.229B
Median
Total Assets (Quarterly) Benchmarks
| Boston Scientific Corp | 38.08B |
| CVS Health Corp | 252.43B |
| Arbutus Biopharma Corp | 140.44M |
| FibroBiologics Inc | 10.47M |
| Biomarin Pharmaceutical Inc | 6.851B |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 4.176B |
| Shareholders Equity (Quarterly) | 3.782B |
| Debt to Equity Ratio | 0.6151 |
| Current Ratio | 1.477 |
| Net Debt Paydown Yield | 0.70% |